Grants per year
- 50 - 75 out of 7,255 results
Search results
-
Active
-
Giron-Krim-amfAR application
Bertoni Giron, L. (PD/PI)
American Foundation for AIDS Research (AmFAR)
10/8/24 → 8/31/25
Project: Research project
-
Prot #1378-0006: EASi-KIDNEY: Studies of Heart & Kidney Protection with BI 690517 in Combination with Empagliflozin: A Multicenter, International, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517
Isakova, T. (PD/PI)
Duke University, Boehringer Ingelheim Pharmaceuticals, Inc.
10/7/24 → 10/7/27
Project: Research project
-
Development of a novel CD73 protein degrader for melanoma immunotherapy
Zhang, B. (PD/PI) & Schiltz, G. E. (Co-Investigator)
Melanoma Research Alliance Foundation
10/4/24 → 10/3/26
Project: Research project
-
Accelerating Medicines Partnership Heart Failure Program
Shah, S. J. (PD/PI)
Foundation for the National Institutes of Health
10/2/24 → 1/2/28
Project: Research project
-
Prot #ALXN2220-ATTRCM-301: DepleTTR-CM: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Amyloid Depleter ALXN2220 in Adult Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Shah, S. J. (PD/PI)
Quintiles, Inc., Alexion Pharmaceuticals, Inc
10/1/24 → 10/1/27
Project: Research project
-
Understanding Anaphylaxis to Platinum-Based Cancer Chemotherapy and Rapid Drug Desensitization that Enables its Use in Allergic Patients
Stevens, W. (PD/PI), Berin, C. (Other), Bochner, B. S. (Other), Kircher, S. M. (Other) & Roque, D. R. (Other)
American Academy of Allergy, Asthma and Immunology
10/1/24 → 9/30/25
Project: Research project
-
Prot #CRDF-004: A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-line Treatment of Metastatic Colorectal Cancer
Benson III, A. B. (PD/PI)
Pfizer Inc., Cardiff Oncology, Inc.
10/1/24 → 10/1/25
Project: Research project
-
Compartment-specific manipulation of NAD+ to mitigate post-injury kidney disease.
Kapitsinou, P. (PD/PI) & Chandel, N. (Co-Investigator)
9/30/24 → 8/31/26
Project: Research project
-
Evaluating equity in antibiotic stewardship and disparities in appropriateness of antibiotic treatment
Evans, C. T. (PD/PI), Balbale, S. N. (Co-Investigator), Dhanani, M. (Co-Investigator) & Sutton, S. H. (Co-Investigator)
Agency for Healthcare Research and Quality
9/30/24 → 7/31/29
Project: Research project
-
Prot #IMC-F106C-301: A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Chandra, S. (PD/PI)
Worldwide Clinical Trials, Inc., Immunocore Limited
9/30/24 → 9/30/27
Project: Research project
-
Single-cell tracking of the transformation of lung adenocarcinoma to small cell lung cancer
Abazeed, M. (PD/PI), Gopal, P. (Co-Investigator) & Patel, J. D. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
9/30/24 → 9/29/27
Project: Research project
-
Prot #BGB-11417-203: An Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of the BCL2 Inhibitor Sonrotoclax (BGB-11417) as Monotherapy and in Combination with Zanubrutinib (BGB-3111) in Patients With Waldenström Macroglobulinemia
Ma, S. (PD/PI)
9/27/24 → 9/27/27
Project: Research project
-
Prot #GS-US-595-6184: A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and N
Stein, R. M. (PD/PI)
PPD Development, Gilead Sciences, Inc
9/27/24 → 9/27/27
Project: Research project
-
Prot #LPS17558: A Phase 4, Randomized, Multicenter, Double-Blind, Parallel-Group, 24 Weeks, Placebo-Controlled Study Followed by 104 Weeks Open-Label to Assess Dupilumab Efficacy on Esophageal Function and Remodeling in Adult Participants with Eosinophili
Gonsalves, N. P. (PD/PI)
ICON Clinical Research, LLC, Sanofi US Services Inc.
9/26/24 → 9/26/27
Project: Research project
-
Prot #NU 23H05: Phase II, Single arm, Open label, study of the combination of Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following Autologous Stem Cell Transplantation (ASCT) or Chimeric Antigen Receptor (CAR) T-cell therapy in Patients
Karmali, R. (PD/PI)
9/23/24 → 9/23/27
Project: Research project
-
Glycomic Modulation of Inflammaging and Immune Functions during HIV Infection
Abdel-Mohsen, M. (PD/PI) & Palella Jr, F. J. (Co-Investigator)
9/22/24 → 8/31/25
Project: Research project
-
Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH)
Yee, L. M. (PD/PI), Bailey, S. C. (Co-Investigator) & Feinglass, J. M. (Co-Investigator)
National Institute on Minority Health and Health Disparities
9/20/24 → 5/31/29
Project: Research project
-
Development of a novel, RNA-interference-based therapeutic to treat prostate cancer
Peter, M. E. (PD/PI) & Murmann, A. E. (Co-Investigator)
NUAgo Therapeutics, Inc., National Cancer Institute
9/19/24 → 8/31/25
Project: Research project
-
IMProving mobility After revasCularizaTion in Peripheral Artery Disease: the IMPACT PAD Trial
McDermott, M. M. (PD/PI), Ho, K. J. (Co-Investigator), Lloyd-Jones, D. M. (Co-Investigator) & Sufit, R. L. (Co-Investigator)
National Heart, Lung, and Blood Institute
9/17/24 → 8/31/25
Project: Research project
-
Project 4: ESI
Budinger, G. S. (Co-Investigator), Chandel, N. (Co-Investigator) & Han, S. (Other)
National Heart, Lung, and Blood Institute
9/17/24 → 7/31/29
Project: Research project
-
Core C: Mouse and Technology Core
Abdala-Valencia, H. (Co-Investigator), Lecuona, E. (Co-Investigator), Wu, Q. (Co-Investigator) & Ridge, K. M. (Other)
National Heart, Lung, and Blood Institute
9/17/24 → 7/31/29
Project: Research project
-
Project 2
Avella Patino, D. M. (Co-Investigator), Pandolfino, J. E. (Co-Investigator) & Perlman, H. R. (Other)
National Heart, Lung, and Blood Institute
9/17/24 → 7/31/29
Project: Research project
-
Core B: Human and Clinical phenotyping Core
Abdala-Valencia, H. (Co-Investigator), Arunachalam, A. (Co-Investigator), Braun, R. I. (Co-Investigator), Kurihara, C. (Co-Investigator), Morales-Nebreda, L. (Co-Investigator), Singer, B. (Co-Investigator), Venkata Subramani, M. (Co-Investigator) & Yan, Y. (Co-Investigator)
National Heart, Lung, and Blood Institute
9/17/24 → 7/31/29
Project: Research project